Literature DB >> 36212268

INFLUENCE OF THE DURATION OF DIABETES AND VIBRATION PERCEPTION THRESHOLD ON THE SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.

P Singh1, S Arora1, A Goyal2, N Mittal1, A Singh1, S Sharma3, D M Shanthaiah4, I K Dardi5.   

Abstract

Background: Erectile dysfunction(ED) in men is a frequent under-reported complication of diabetes mellitus, which is becoming significant health problem worldwide. Aims: The study aims to determine the prevalence and risk factors for development of ED in North Indian patients with type 2 diabetes mellitus.
Methods: We used international index of erectile function (IIEF-5) for the assessment of ED in 796 patients with type 2 diabetes mellitus. We recorded the age, duration of diabetes, glycemic status, body mass index, diabetes medications, microvascular and macrovascular complications.
Results: The mean age of patients in the study was 49.38 ± 9.52 years. The prevalence of ED in patients with type 2 diabetes mellitus was 79.4%. Logistic regression analysis revealed that age, body mass index, glycemic control, insulin therapy, retinopathy and nephropathy was not significantly associated with erectile dysfunction in patients with type 2 diabetes mellitus. Duration of diabetes (OR = 1.054, 95% CI 1.007 to 1.102, P=0.023) and vibration perception threshold (OR = 1.071, 95% CI 1.042 to 1.102, P=0.000) were identified as key risk factors for development of ED.
Conclusion: Duration of diabetes and peripheral neuropathy emerged as significant risk factors for development of severe erectile dysfunction. ©2022 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Erectile dysfunction; Peripheral neuropathy; Type 2 diabetes mellitus; Vibration perception threshold

Year:  2022        PMID: 36212268      PMCID: PMC9512378          DOI: 10.4183/aeb.2022.174

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  35 in total

Review 1.  Diabetic autonomic neuropathy.

Authors:  Aaron I Vinik; Raelene E Maser; Braxton D Mitchell; Roy Freeman
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

2.  Severity of erectile dysfunction and prevalence of premature ejaculation among type 2 diabetic men referred to an ED clinic of a tertiary care centre.

Authors:  Vijay Viswanathan; Sarweswar Agarwal; Satyavani Kumpatla
Journal:  J Assoc Physicians India       Date:  2009-08

3.  The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus.

Authors:  Adel Al-Hunayan; Manal Al-Mutar; Elijah O Kehinde; Lukman Thalib; Mounir Al-Ghorory
Journal:  BJU Int       Date:  2006-10-09       Impact factor: 5.588

4.  Albuminuria is an independent risk factor of erectile dysfunction in men with type 2 diabetes.

Authors:  Yao-Chi Chuang; Min-Shen Chung; Pei-Wen Wang; Wei-Chia Lee; Chung-Dar Chen; Hsueh-Wen Chang; Kuender D Yang; Michael B Chancellor; Rue-Tsuan Liu
Journal:  J Sex Med       Date:  2012-01-03       Impact factor: 3.802

Review 5.  Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae.

Authors:  Carlos Campos
Journal:  Postgrad Med       Date:  2012-11       Impact factor: 3.840

6.  Nerve conduction studies and vibration perception thresholds in diabetic and uremic neuropathy.

Authors:  R R Klima; A H Weigand; J A DeLisa
Journal:  Am J Phys Med Rehabil       Date:  1991-04       Impact factor: 2.159

Review 7.  Erectile dysfunction in diabetes mellitus.

Authors:  Lasantha S Malavige; Jonathan C Levy
Journal:  J Sex Med       Date:  2009-02-10       Impact factor: 3.802

8.  Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease.

Authors:  Babu Lal Meena; Dhanpat Kumar Kochar; Tulsi Das Agarwal; Raghvendra Choudhary; Abhishek Kochar
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

Review 9.  Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat.

Authors:  I Sáenz de Tejada
Journal:  Int J Impot Res       Date:  2004-06       Impact factor: 2.896

10.  Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea.

Authors:  Da Hea Seo; Shinae Kang; Yong Ho Lee; Jung Yoon Ha; Jong Suk Park; Byoung Wan Lee; Eun Seok Kang; Chul Woo Ahn; Bong Soo Cha
Journal:  Endocrinol Metab (Seoul)       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.